A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/00 (2006.01) A61K 39/145 (2006.01) C07K 14/11 (2006.01) C07K 14/705 (2006.01) C12N 15/85 (2006.01)
Patent
CA 2404709
The present invention relates to a vaccine containing a nucleic acid molecule comprising (a) a promoter that is specifically active in antigen presenting cells; and, operatively linked thereto (b) a nucleic acid sequence encoding an antigen. The present invention also relates to a method of vaccinating a mammal wherein the vaccine of the invention is administered to a mammal at a suitable dose.
La présente invention concerne un vaccin contenant une molécule d'acide nucléique comprenant: (a) un promoteur spécifiquement actif dans les cellules présentatrices d'antigène; et, fonctionnellement reliée au promoteur précité, (b) une séquence nucléotidique codant un antigène. L'invention se rapporte également à un procédé de vaccination d'un mammifère selon lequel on administre à un mammifère une dose adéquate du vaccin de l'invention.
Borden Ladner Gervais Llp
Glaxo Group Ltd
LandOfFree
Highly efficient dendritic cell-targeted dna-vaccination does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Highly efficient dendritic cell-targeted dna-vaccination, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Highly efficient dendritic cell-targeted dna-vaccination will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1626066